Table 2.
The differences among the non-medicated ADHD group, medicated ADHD group, and the HC group in clinical characteristics.
| Non-medicated ADHD group (N = 110) |
Medicated ADHD group (N = 189) |
HC group (N =122) |
F value | post hoc t test | |
|---|---|---|---|---|---|
| ADHD-RS | 28.84 ± 7.72 | 26.42 ± 10.34 | 5.92 ± 4.55 | 254.710*** | Non-medicated ADHD* > Medicated ADHD*** > HC |
| SAS | 48.43 ± 10.19 | 40.93 ± 10.08 | 31.65 ± 5.72 | 87.724*** | Non-medicated ADHD*** > Medicated ADHD*** > HC |
| SDS | 54.44 ± 12.63 | 45.80 ± 11.77 | 33.13 ± 6.64 | 99.293*** | Non-medicated ADHD*** > Medicated ADHD*** > HC |
| ATQ total score | 74.18 ± 24.63 | 67.43 ± 23.08 | 37.07 ± 8.30 | 100.258*** | Non-medicated ADHD* > Medicated ADHD*** > HC |
| DAS total score | 151.83 ± 36.49 | 145.54 ± 33.82 | 108.21 ± 24.61 | 54.740*** | Non-medicated ADHD > Medicated ADHD*** > HC |
| WHOQOL-BREF Psychological domain | 41.09 ± 16.05 | 47.00 ± 17.53 | 75.69 ± 13.24 | 137.325*** | Non-medicated ADHD** < Medicated ADHD*** < HC |
HC group: the healthy control group; SAS, Self-Rating Anxiety Scale; SDS, Self-Rating Depression Scale; ATQ, Automatic Thoughts Questionnaire; DAS, Dysfunctional Attitudes Scales; WHOQOL-BREF, World Health Organization Quality of Life-Brief Version; *: p < 0.05; **: p < 0.01; ***: p < 0.001.